# US 2012/0252050 A1 · Methods for assessing risk of bone fracture

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252050 A1
- Document ID: US20120252050A1
- Status: Published application
- Kind: A1
- Application number: 13/301,952
- Filed: 2011-11-22
- Published: 2012-10-04
- Earliest claimed: 2004-06-22
- Assignees: Crescent Diagnostics Limited
- Inventors: Mark Robert Towler; Ernest Poku
- Web page: https://patentgrep.com/patent/US20120252050A1

## CPC

- A61B 5/4504: {Bones (A61B5/4547 takes precedence)}
- A61B 5/0075: {by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy (A61B5/0071 takes precedence)}
- A61B 5/4509: {Bone density determination}
- A61B 5/4869: {Determining body composition}
- A61B 5/6826: {Finger}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- G01N 21/65: Raman scattering
- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- G01N 2030/8831: {involving peptides or proteins}
- G01N 2333/4742: Keratin; Cytokeratin
- G01R 33/465: applied to biological material, e.g. in vitro testing
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G01R: MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES (indicating correct tuning of resonant circuits H03J3/12)

## Abstract

The invention generally relates to methods for assessing risk of bone fracture. In certain embodiments, methods of the invention involve a) conducting an assay to determine a characteristic of keratinized tissue obtained from a mammal, b) analyzing at least one bone-fracture risk factor associated with the mammal, and c) correlating results from steps (a) and (b), thereby assessing the risk of bone fracture of a bone of the mammal.

## Claims

### Claim 1

A method for assessing risk of bone fracture of a bone of a mammal, the method comprising:
a) conducting an assay to determine a characteristic of keratinized tissue obtained from a mammal;
b) analyzing at least one bone-fracture risk factor associated with the mammal; and
c) correlating results from steps (a) and (b), thereby assessing the risk of bone fracture of a bone of the mammal.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the assay is performed in situ.

### Claim 3 (depends on 1)

The method according to claim 1, wherein assay is measuring chemical changes in the tissue.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the chemical changes in the tissue are changes in levels of sulfur bonding.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the assay is performed by a technique selected from the group consisting of: Raman spectroscopy; nuclear magnetic resonance spectroscopy; infrared spectroscopy; chiroptical techniques; mass spectrometry; chromatography; and reactions with Elman's reagent.

### Claim at position 6

6-7. (canceled)

### Claim 8 (depends on 1)

The method according to claim 1, wherein the assay comprises measuring changes in chemical composition of the tissue by a Raman spectroscopy technique.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the measurement is obtained at a depth of least 50 microns into the tissue.

### Claim 10 (depends on 8)

The method according to claim 8, further comprising performing a spectral analysis of obtained Raman spectra by multivariate analysis.

### Claim 11 (depends on 8)

The method according to claim 8, wherein changes in chemical composition of the tissue are changes in levels of sulfur bonding in proteins in the tissue.

### Claim 12 (depends on 8)

The method according to claim 8, wherein the Raman spectroscopy measures a peak or set of peaks in a 0-4000 cm−1 spectral region.

### Claim 13 (depends on 8)

The method according to claim 8, wherein the Raman spectroscopy measures a peak selected from the group consisting of: a peak at about 510 cm−1; a peak at about 621 cm−1; and a peak at about 643 cm−1.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the keratinized tissue is selected from the group consisting of: nail; hair; and skin.

### Claim 15 (depends on 14)

The method according to claim 14, wherein the nail is a clipped finger nail or toe nail.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the clipped finger nail or toe nail has been archived for a period of time.

### Claim 17 (depends on 1)

The method according to claim 1, wherein the bone is a hip bone.

### Claim 18 (depends on 1)

The method according to claim 1, wherein the bone-fracture risk factor is selected from the group consisting of: age, body mass index (BMI), smoking status, thyroid hormone use, diet, age at menopause, alcohol consumption, diagnosis of osteoporosis, and a combination thereof.

### Claim 19 (depends on 1)

The method according to claim 1, wherein prior to the conducting step, the method further comprises obtaining the keratinized tissue from the mammal.

### Claim 20 (depends on 1)

The method according to claim 1, wherein the mammal is a human female.

### Claim 21 (depends on 20)

The method according to claim 20, wherein the female is post-menopausal.

### Claim 22 (depends on 21)

The method according to claim 21, wherein the female is younger than 65 years of age.

### Claim 23

A method for assessing risk of bone fracture of a bone of a mammal, the method comprising:
measuring changes in chemical composition of keratinized tissue by a Raman spectroscopy technique; and
comparing obtained Raman spectra to a set of reference spectra, thereby assessing the risk of bone fracture of a bone of the mammal.

### Claim 24 (depends on 23)

The method according to claim 23, wherein the measurement is obtained at a depth of least 50 microns into the tissue.

### Claim 25 (depends on 23)

The method according to claim 23, wherein changes in chemical composition of the tissue are changes in levels of sulfur bonding in proteins in the tissue.

### Claim 26 (depends on 23)

The method according to claim 23, wherein the Raman spectroscopy measures a peak or set of peaks in a 0-4000 cm−1 spectral region.

### Claim 27 (depends on 23)

The method according to claim 23, wherein the Raman spectroscopy measures a peak selected from the group consisting of: a peak at about 510 cm−1; a peak at about 621 cm−1; and a peak at about 643 cm−1.

### Claim 28 (depends on 23)

The method according to claim 23, wherein the keratinized tissue is selected from the group consisting of: nail; hair; and skin.

### Claim 29 (depends on 28)

The method according to claim 28, wherein the nail is a clipped finger nail or toe nail.

### Claim 30 (depends on 29)

The method according to claim 29, wherein the clipped finger nail or toe nail has been archived for a period of time.

### Claim 31 (depends on 23)

The method according to claim 23, wherein the bone is a hip bone.

### Claim 32 (depends on 23)

The method according to claim 23, wherein prior to the measuring step, the method further comprises obtaining the keratinized tissue from the mammal.

### Claim 33 (depends on 23)

The method according to claim 23, wherein the mammal is a human female.

### Claim 34 (depends on 33)

The method according to claim 33, wherein the female is post-menopausal.

### Claim 35 (depends on 34)

The method according to claim 34, wherein the female is younger than 65 years of age.

### Claim 36 (depends on 23)

The method according to claim 23, wherein prior to the performing step, the method further comprises performing a spectral analysis of obtained Raman spectra by multivariate analysis.

### Claim 37 (depends on 23)

The method according to claim 23, further comprising a spectral analysis of obtained Raman spectra by multivariate analysis.
